Trial · NCT07898098
Early Rehabilitation After Transfemoral Amputation in Moderately Active Patients Using the Avior Knee
NCT07898098, Not applicable, Enrolling by invitation, Median
3 sourcestrials-2026-11-12-0.5.0
Download JSON
Cite this record
ConductScience Library. Early Rehabilitation After Transfemoral Amputation in Moderately Active Patients Using the Avior Knee. Trials, record NCT07898098. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07898098
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Early Rehabilitation After Transfemoral Amputation in Moderately Active Patients Using the Avior Knee
- NCT number
- NCT07898098
- Status
- Enrolling by invitation
- Phases
- Not applicable
- Enrollment
- 33 participants, estimated
- Lead sponsor
- Median
- Conditions
- Transfemoral Amputees
- Interventions
- knee prothesis - Avior, knee prothesis - Kenevo
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mobility of lower-limb prosthesis users: PLUS-M™ 12-Item Short Form T-score | Baseline (beginning of rehabilitation); 3 weeks after baseline; 6 weeks after baseline (end of rehabilitation); 12 weeks after baseline (first follow-up); 18 weeks after baseline (second follow-up); and 24 weeks after baseline (last follow-up). | Mobility of lower-limb prosthesis users is assessed using the Prosthetic Limb Users Survey of Mobility (PLUS-M™) 12-Item Short Form (v1.2). The questionnaire consists of 12 items assessing the participant's ability to perform various mobility-related activities. Each item is rated on a 5-level response scale. The responses are scored according to the PLUS-M™ scoring procedure to obtain a standardized PLUS-M™ T-score. The raw score is used only to determine the corresponding T-score. Higher T-scores indicate greater mobility. Unit of Measure: PLUS-M™ T-score |
| Secondary | Health-related quality of life: EQ-5D-5L index score | Baseline (beginning of rehabilitation); 3 weeks after baseline; 6 weeks after baseline (end of rehabilitation); 12 weeks after baseline (first follow-up); 18 weeks after baseline (second follow-up); and 24 weeks after baseline (last follow-up). | Health-related quality of life is assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). The questionnaire assesses five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is rated on a 5-level scale ranging from 1 (no problems) to 5 (extreme problems or unable to perform the activity, as applicable). The responses across the five dimensions are converted into a single EQ-5D-5L index score using the German EQ-5D-5L value set (Ludwig et al., 2018). Unit of Measure: EQ-5D-5L index score |
| Secondary | Health-related quality of life: EQ Visual Analogue Scale (EQ VAS) score | Baseline (beginning of rehabilitation); 3 weeks after baseline; 6 weeks after baseline (end of rehabilitation); 12 weeks after baseline (first follow-up); 18 weeks after baseline (second follow-up); and 24 weeks after baseline (last follow-up). | Self-rated health status is assessed using the EQ Visual Analogue Scale (EQ VAS) of the EQ-5D-5L questionnaire. Participants rate their current health status on a visual analogue scale ranging from 0 (the worst health you can imagine) to 100 (the best health you can imagine). Unit of Measure: EQ VAS score (0-100) |
| Secondary | Reintegration into normal living: Reintegration to Normal Living Index (RNLI) total score | Baseline (beginning of rehabilitation); 3 weeks after baseline; 6 weeks after baseline (end of rehabilitation); 12 weeks after baseline (first follow-up); 18 weeks after baseline (second follow-up); and 24 weeks after baseline (last follow-up). | Reintegration into normal living is assessed using the 11-item Reintegration to Normal Living Index (RNLI). The questionnaire assesses the participant's perceived ability to participate in and manage activities, roles, and relationships in daily life. Each item is rated on a 10-point scale ranging from 0 (does not describe my situation at all) to 10 (describes my situation perfectly). The scores of the 11 items are summed to obtain a total RNLI score ranging from 0 to 110 points. Higher scores indicate greater reintegration into normal living. Unit of Measure: RNLI total score (0-110 points) |
| Secondary | Locomotor capabilities: Locomotor Capabilities Index-5 (LCI-5) total score | Baseline (beginning of rehabilitation); 3 weeks after baseline; 6 weeks after baseline (end of rehabilitation); 12 weeks after baseline (first follow-up); 18 weeks after baseline (second follow-up); and 24 weeks after baseline (last follow-up). | Locomotor capabilities with a lower-limb prosthesis are assessed using the Locomotor Capabilities Index-5 (LCI-5). The questionnaire consists of 14 items assessing the participant's ability to perform basic and advanced locomotor activities while using a prosthesis. Each item is scored from 0 (not able to perform the activity) to 4 (able to perform the activity independently without walking aids). Item scores are summed to obtain the total LCI-5 score. Higher scores indicate greater locomotor capability. Unit of Measure: LCI-5 total score (0-56 points) |
| Secondary | Independence in activities of daily living: Barthel Index total score | Baseline (beginning of rehabilitation); 3 weeks after baseline; 6 weeks after baseline (end of rehabilitation); 12 weeks after baseline (first follow-up); 18 weeks after baseline (second follow-up); and 24 weeks after baseline (last follow-up). | Independence in activities of daily living is assessed using the Barthel Index. The assessment covers 10 activities of daily living. Individual activities are scored according to the Barthel Index scoring procedure and combined to obtain a total Barthel Index score. Higher scores indicate greater independence in activities of daily living. Unit of Measure: Barthel Index total score (0-100 points) |
| Secondary | Functional mobility: Timed Up and Go (TUG) test completion time | Baseline (beginning of rehabilitation); 3 weeks after baseline; and 6 weeks after baseline (end of rehabilitation). | Functional mobility is assessed using the Timed Up and Go (TUG) test. The participant starts in a seated position, stands up, walks 3 meters, turns around, walks back, and sits down. The time required to complete the test is measured from initiation of the movement until the participant returns to the seated position. Unit of Measure: Seconds |
| Secondary | Falls: number of falls | Baseline (beginning of rehabilitation); 3 weeks after baseline; 6 weeks after baseline (end of rehabilitation); 12 weeks after baseline (first follow-up); 18 weeks after baseline (second follow-up); and 24 weeks after baseline (last follow-up). | The occurrence of falls is assessed using a study-specific fall survey. The number of falls experienced by the participant during the specified assessment period is recorded. Unit of Measure: Number of falls |
| Secondary | Fear of falling: Numerical Rating Scale (NRS) score | Baseline (beginning of rehabilitation); 3 weeks after baseline; 6 weeks after baseline (end of rehabilitation); 12 weeks after baseline (first follow-up); 18 weeks after baseline (second follow-up); and 24 weeks after baseline (last follow-up). | Fear of falling is assessed using a numerical rating scale (NRS) included in the study-specific fall survey. The participant rates their fear of falling on the NRS. Unit of Measure: NRS score |
| Secondary | Residual limb wound healing: Pressure Ulcer Scale for Healing (PUSH) total score | Baseline (beginning of rehabilitation); 3 weeks after baseline; and 6 weeks after baseline (end of rehabilitation). | Residual limb wound healing is assessed using the Pressure Ulcer Scale for Healing (PUSH). The PUSH assesses three wound characteristics: wound surface area, wound exudate, and wound tissue type. Wound surface area is determined by measuring the maximum wound length and width and calculating length × width. The resulting wound area is categorized and scored from 0 to 10 points. Wound exudate is categorized as none, scant, moderate, or heavy and scored from 0 to 3 points. Wound tissue type is categorized and scored from 0 to 4 points. The three component scores are summed to obtain a total PUSH score ranging from 0 to 17 points. Unit of Measure: PUSH total score (0-17 points) |
1 to 10 of 21Source ClinicalTrials.gov
See all 21 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 28273329 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07898098
GET https://conductscience.org/api/trials/v1/NCT07898098/registered?page=2